Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_2
2
22%
Ph phase_1
1
11%
Ph phase_3
5
56%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(8)

Detailed Status

Completed8
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 35 (62.5%)

Trials by Status

completed889%
not_yet_recruiting111%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_2

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

NCT07671495
not_yet_recruiting

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

NCT06926647
completedphase_3

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

NCT04534725
completedphase_2

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

NCT00363649
completedphase_3

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

NCT00006237
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07671495Phase 2

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Completed
NCT06926647

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Not Yet Recruiting
NCT04534725Phase 3

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

Completed
NCT00363649Phase 2

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Completed
NCT00006237Phase 3

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Completed
NCT00065468Phase 3

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

Completed
NCT00005615Phase 1

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Completed
NCT00291369Phase 3

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Completed
NCT00004804Phase 3

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

Completed

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9